文献速递慢性肾脏病遗传性与小管间质肾病

尿渗透质排泄增加提示慢性肾脏病严重程度与进展速度

Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究在227例eGFR 9.4-130 mL/min/1.73 m²的CKD患者中分析尿液代谢物谱与eGFR下降的关系,并在57例回顾性子集中寻找独立于基线eGFR的预后标志物。线性模型显示尿甜菜碱和肌醇浓度升高是CKD进展的显著预后标志物(均P < 0.05),小鼠转录组分析提示Slc6a12和Slc5a11 mRNA表达降低与肾小管渗透质转运缺陷一致。

要点

  • 尿甜菜碱和肌醇浓度升高与CKD进展显著相关(均P < 0.05)。
  • 11种尿液代谢物与eGFR降低显著相关。
  • 肾小管渗透质转运缺陷可能加重肾细胞损伤并促进CKD进展。

核心结论

  • 尿甜菜碱和肌醇浓度升高是CKD进展的显著预后标志物,独立于基线eGFR。
  • 肾脏渗透质调节失衡导致肾细胞损伤增加,从而促进CKD进展。

研究设计与样本

  • CKD患者队列(n = 227),eGFR范围9.4-130 mL/min/1.73 m²,分析尿液代谢物谱与eGFR下降的关系。
  • 嵌套回顾性子集(n = 57)用于寻找独立于基线eGFR的CKD进展预后代谢标志物。
  • 小鼠肾衰竭模型的转录组分析用于验证选定的代谢组学发现。

主要发现

  • 一般线性模型显示11种尿液代谢物与eGFR降低显著相关。
  • 线性模型显示尿甜菜碱浓度升高(P < 0.05)和尿肌醇浓度升高(P < 0.05)是CKD进展的显著预后标志物。
  • 小鼠肾组织转录组分析发现Slc6a12和Slc5a11 mRNA表达降低,与这些渗透质的肾小管转运缺陷一致。

关键数值与推荐

  • 尿甜菜碱和肌醇浓度升高与CKD进展显著相关,均P < 0.05。
  • 队列eGFR范围为9.4-130 mL/min/1.73 m²。

临床怎么用

  • 尿甜菜碱和肌醇可能作为CKD诊断和预后评估的无创生物标志物。
  • 监测尿渗透质排泄有助于识别进展风险较高的CKD患者。

局限性

  • 预后标志物分析基于回顾性子集(n = 57),样本量有限。
  • 小鼠转录组结果需在人类中进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic kidney disease (CKD) is a recognized global health problem. While some CKD patients remain stable after initial diagnosis, others can rapidly progress towards end-stage renal disease (ESRD). This makes biomarkers capable of detecting progressive forms of CKD extremely valuable, especially in non-invasive biofluids such as urine. Screening for metabolite markers using non-targeted metabolomic techniques like nuclear magnetic resonance spectroscopy is increasingly applied to CKD research. METHODS: A cohort of CKD patients (n = 227) with estimated glomerular filtration rates (eGFRs) ranging from 9.4-130 mL/min/1.73 m2 was evaluated and urine metabolite profiles were characterized in relation to declining eGFR. Nested in this cohort, a retrospective subset (n = 57) was investigated for prognostic metabolite markers of CKD progression, independent of baseline eGFR. A transcriptomic analysis of murine models of renal failure was performed to validate selected metabolomic findings. RESULTS: General linear modeling revealed 11 urinary metabolites with significant associations to reduced eGFR. Linear modelling specifically showed that increased urine concentrations of betaine (P < 0.05) and myo-inositol (P < 0.05) are significant prognostic markers of CKD progression. CONCLUSIONS: Renal organic osmolytes, betaine and myo-inositol play a critical role in protecting renal cells from hyperosmotic stress. Kidney tissue transcriptomics of murine preclinical experimentation identified decreased expression of Slc6a12 and Slc5a11 mRNA in renal tissue consistent with defective tubular transport of these osmolytes. Imbalances in renal osmolyte regulation lead to increased renal cell damage and thus more progressive forms of CKD. Increases in renal osmolytes in urine could provide clinical diagnostic and prognostic information on CKD outcomes.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Gil RB, Ortiz A, Sanchez-Niño MD, et al. Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate. Nephrol Dial Transplant. 2018. PMID: 29554320. doi:10.1093/ndt/gfy020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。